Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.
about
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S micePathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and RehabilitationDegeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseWhat can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Evaluation of Models of Parkinson's DiseaseBehavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug AddictionOxidative stress and Parkinson's diseasePsychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson's Disease: A Systematic ReviewNeuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseSigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neuronsWorsening of Verbal Fluency After Deep Brain Stimulation in Parkinson's Disease: A Focused ReviewSerotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseParkinson's disease: animal models and dopaminergic cell vulnerabilityReview: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibitionAntiarrhythmics cure brain arrhythmia: The imperativeness of subthalamic ERG K+ channels in parkinsonian discharges.Anticipatory and Compensatory Postural Adjustments in Response to External Lateral Shoulder Perturbations in Subjects with Parkinson's Disease.StartReact effects support different pathophysiological mechanisms underlying freezing of gait and postural instability in Parkinson's disease.Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission.Effects of subthalamic nucleus stimulation on emotional prosody comprehension in Parkinson's disease.Imaging genetics approach to Parkinson's disease and its correlation with clinical score.Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.Scaling and coordination deficits during dynamic object manipulation in Parkinson's disease.Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Clinical profile of Parkinson's disease in the Gumei community of Minhang district, Shanghai.Subregional 6-[18F]fluoro-ʟ-m-tyrosine uptake in the striatum in Parkinson's disease.Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease.Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.Comparison of the D₁ dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease.Accounting for movement increases sensitivity in detecting brain activity in Parkinson's diseaseAlpha and beta EEG power reflects L-dopa acute administration in parkinsonian patientsInvestigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Non-motor and motor features in LRRK2 transgenic mice.Widespread increase of functional connectivity in Parkinson's disease with tremor: a resting-state FMRI study.Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease.Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's diseaseCurrent perspectives on deep brain stimulation for severe neurological and psychiatric disordersComparative diffusion tractography of corticostriatal motor pathways reveals differences between humans and macaques.
P2860
Q24317631-78939C1D-54DC-4798-A3B7-CCA68708EEAEQ26745654-7EDD3DA3-6FB6-4DF4-8F83-DBF4147DBE1BQ26750370-02FFD991-E704-473A-9CF4-2984B12D443FQ26767268-B1BFC571-CB33-44FE-BF15-228843500CA7Q26772843-BDB699E8-DA7D-4518-A0A4-7DCB4227227AQ26783948-F8440BD9-AE5B-4534-BE03-386FD4599728Q26798897-295140E7-AA1E-4C81-B79C-9ECA177F14A3Q26800109-2B53D00D-3DBA-4562-AB80-AE2A79B86BDCQ26995351-0445C664-E07E-44A8-9DDF-EC04662C916BQ27330088-5BD60B20-333F-45A7-A674-98DBEDDFFA4BQ28067538-52C0A946-E46F-4440-ABC8-36320E854405Q28079379-C82DC94C-25B1-482B-A5B5-DF360467F0DBQ28080503-BB26F200-2B40-4FE9-AB66-DBFCE84339E0Q28394979-ED58AF03-F3DD-45AE-A1E7-2D848FFA44DDQ29994716-D6482F5E-D105-4DCF-91B7-075C6739B196Q30383792-F6DEEE75-A6E3-43D1-AFF2-71A528D0E117Q30414951-501C5FBD-BA4E-4290-B22A-9045A1C50D78Q30472919-3713F2DD-6565-44D7-8E6D-DB85849B8276Q30475554-97E27243-8E12-4AB6-A5EC-4FDA0306CFA6Q33587357-9C6AC0DE-0859-4A24-BEF1-47B358F74814Q33604446-3D049102-945D-4FF1-9697-B3417FC40286Q33688838-668CD038-2390-46FE-AA24-9143E2410255Q33781498-52A96AA9-A399-431C-8162-2D43C2F40676Q33813336-B77055CF-5180-445E-8720-F52FE867AEF4Q33846298-6096EA84-8371-4C69-96E8-36ED7CD9F407Q33853332-86905B2D-B67F-4BA3-9F29-B7E8EAFDC597Q33855598-C14DFED7-14C5-46D7-A4B4-52AC6A3D46BFQ34048566-2822956F-CA37-43AB-B605-E602B6AD60C6Q34165820-A3023079-BD53-48A7-B753-4A71DD0CB065Q34245009-9FB5355C-8631-4DC8-B991-7F3ED33CE1F7Q34260096-C883F6B3-2787-4D31-83A5-C104EAA8506CQ34522105-CB7D0307-A0E8-4E31-8E99-B9BFBE0D5619Q34703195-FAAB4CD8-4B4E-4EC7-BB01-EB22CD1B1527Q34922393-FE2985AD-2735-48C7-A498-B09384B018D4Q35042213-F51E48BF-B6C5-4F07-B308-E288258492B3Q35071909-445D17DB-3639-4360-B25B-EA93A4352468Q35072636-800910D1-DAA5-4404-BDA5-7570766007EFQ35269971-80D26DBC-F75B-43DB-BAB7-CA9680E9E823Q35444215-F8E95F64-ABF9-45BD-AD1C-895E7B389845Q35560206-0F9E7BB5-AF9E-4682-81BA-2DDC7039D6A4
P2860
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Initial clinical manifestation ...... pathophysiological mechanisms.
@ast
Initial clinical manifestation ...... pathophysiological mechanisms.
@en
type
label
Initial clinical manifestation ...... pathophysiological mechanisms.
@ast
Initial clinical manifestation ...... pathophysiological mechanisms.
@en
prefLabel
Initial clinical manifestation ...... pathophysiological mechanisms.
@ast
Initial clinical manifestation ...... pathophysiological mechanisms.
@en
P2093
P50
P1433
P1476
Initial clinical manifestation ...... pathophysiological mechanisms
@en
P2093
José A Obeso
Marjan Jahanshahi
Paul Krack
Raúl Macias
P304
P356
10.1016/S1474-4422(09)70293-5
P577
2009-12-01T00:00:00Z